Navigation Links
Shire Recognized by ISPE Facility of the Year Awards Program
Date:1/24/2011

LEXINGTON, Mass., Jan. 24, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the Project Atlas manufacturing facility in Lexington, Massachusetts has been recognized with an honorable mention in the ISPE (International Society for Pharmaceutical Engineering) Facility of the Year Awards program.

Project Atlas was selected from a group of 26 state-of-the-art projects constructed in 11 different countries. The Facility of the Year Awards program recognizes pharmaceutical manufacturing projects that utilize new and innovative technologies to enhance the delivery of a quality project, as well as reduce the cost of producing high-quality medicines.

Among the reasons given for the recognition, the judges noted Shire's extensive deployment of single-use technologies at commercial scale, and the ability to overcome challenges and make technical adaptations to implement fully single-use upstream process technology at a 2,000 liter scale. As a result, the facility was effectively built faster, with reduced investment and lower utility requirements.

"We are honored to be recognized by ISPE for our work on the Atlas Project," said Bill Ciambrone, Head of Technical Operations at Shire HGT. "In less than three years, we have successfully built, commissioned, and performed validation runs in a facility that enables us to develop therapies to treat those suffering from orphan diseases around the world. As the ISPE judges noted, Project Atlas is the embodiment of Shire's vision – which is to be as brave as the people we help."

The Atlas facility supports the manufacture of REPLAGAL® (agalsidase alfa), VPRIV® (velaglucerase alfa), and Shire's robust pipeline of future development programs.  Along with Atlas, Shire owns four buildings in Lexington that serve as the global ce
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Reportlinker Adds Shire plc: PharmaVitae Profile
2. Shire Presents Positive New Data at the 60th Annual American Society of Human Genetics (ASHG) for Patients with Type 1 Gaucher Disease
3. Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010
4. Atrium Recognized by New Hampshire Bio/Medical Council
5. Shire Update on ProAmatine(R) (midodrine HCl)
6. Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
7. Pentasa(R) - Shire Receives Ruling From FDA on Citizens Petition
8. Shire Purchases Strategic Site in Massachusetts
9. Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals
10. Area Residents Can Give a Little, Help A Lot at Shires BIG GIVE
11. Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2014)... endedChange %  30 September 201430 September 2013Turnover 546,011 , 534,641 ... 384,242 , 339,113 , 13.3 Hospital ... , 49.5 Medical Insurance Administration Service Income , ... and Accessories Sales , 94,580 , 142,683 ... , 9,219 , (68.4) Impairment Loss on Fixed ...
(Date:11/26/2014)... Nov. 26, 2014  Thoratec Corporation (NASDAQ: ... support therapies to save, support and restore failing hearts, ... investor conferences. On Tuesday, December 2, the ... Piper Jaffray Healthcare Conference.  D. Keith Grossman , ... on the company beginning at 11:30 a.m., Eastern Standard ...
(Date:11/26/2014)... , Nov. 26, 2014  Cohen, Placitella ... behalf of investors who purchased Nymox Pharmaceutical Corporation ... during the period from January 31, 2011 through ... whether Nymox and certain of its officers and ... in violation of Sections 10(b) and 20(a) of ...
Breaking Medicine Technology:Golden Meditech Announces 2014 / 2015 Interim Results 2Golden Meditech Announces 2014 / 2015 Interim Results 3Golden Meditech Announces 2014 / 2015 Interim Results 4Golden Meditech Announces 2014 / 2015 Interim Results 5Golden Meditech Announces 2014 / 2015 Interim Results 6Golden Meditech Announces 2014 / 2015 Interim Results 7Golden Meditech Announces 2014 / 2015 Interim Results 8Thoratec Announces Presentations At Investor Conferences For December 2014 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3
... Control, WASHINGTON, Jan. 10 To help ... risks during times,of health crisis, DuPont (NYSE: ... products, DuPont(TM) Corian(R) solid surface, has been selected,by ... The product,recently was incorporated into a children,s ward ...
... South Korea, Jan. 10 Celltrion, Inc., a ... and CSL Limited, Australia,s leading biopharmaceutical,company, announced today ... supply of CSL 360, an experimental monoclonal antibody ... Phase I clinical trials for CSL,360 are currently ...
Cached Medicine Technology:DuPont Provides Technology for Washington Hospital Center's Emergency Department 2DuPont Provides Technology for Washington Hospital Center's Emergency Department 3DuPont Provides Technology for Washington Hospital Center's Emergency Department 4Celltrion and CSL Announce Collaboration to Develop and Manufacture Monoclonal Antibody 2
(Date:11/28/2014)... Brosix is always making changes to its infrastructure architecture ... efficient, effective, and secure experience. Most recently, the company ... ability to setup local servers for each country or ... around the globe. , 2. The ability to setup ... require millions of users in one network. , 3. ...
(Date:11/28/2014)... Dr. Diane Walder, one of the South ... Dr. Bridgit Nolan to her practice as a cosmetic ... her dermatology residency at the University of Miami Miller ... Nolan to join her practice because of her ... only does Dr. Nolan strive to provide the utmost ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Mirena ... move forward in New Jersey’s Bergen County Superior ... consolidated litigation established there is quickly approaching 1,300, ... on November 18th shows 1,293 lawsuits now pending ... lawsuits that allege complications resulting from spontaneous migration ...
(Date:11/28/2014)... 28, 2014 Miami's Plastic Surgery of ... Practice founder Dr. Jeffrey Epstein is excited ... a groundbreaking WordPress platform, the site is uniquely designed ... Currently, up to 75% of all prospective rhinoplasty patients ... people are logging on with smartphones, tablets, and laptops, ...
(Date:11/28/2014)... 28, 2014 Secura Consultants, based ... insurance marketing organizations in the country focused on ... protection marketplace. Secura Consultants is proud to offer ... Financial Group, a leading global financial company. , ... With the ownership interest comes the need for ...
Breaking Medicine News(10 mins):Health News:Brosix Infrastructure Architecture Changes to Benefit Users 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Secura Consultants Offers Complimentary Buy-Sell Agreement Reviews 2
... study led by the University of Leicester has concluded that ... a doctor,s surgery helps to reduce emergency hospital admissions. ... at the University of Leicester revealed a correlation between patients ... admissions. The research, published in Emergency Medical Journal ...
... is available in French and Spanish . ... herpesviruses family, which also includes the herpes simplex virus and ... cause multiple sclerosis, a condition affecting the central nervous system, ... University of Granada scientists that analyzed the presence of ...
... team led by developmental biologist Professor Christophe Marcelle has nailed ... differentiate into specialised cells that form the skeletal muscles of ... journal Nature on Monday (May 16). Scientists ... processes that cause stem cells in the early embryo to ...
... by half in the radiation dose to which cardiac ... "feasible", according to an Israeli study. Results from ... at the International Conference of Non-Invasive Cardiovascular Imaging (ICNC) ... the world,s major scientific events in nuclear cardiology and ...
... study conducted by researchers in Connecticut, the Wii Fit offers ... and one that, because it is enjoyable, patients are ... COPD patients exercised at a relatively high percent of their ... indicating the Wii Fit may be a reasonable home-based exercise ...
... -- Patients who undergo angioplasty to unblock a clogged ... in a cardiac rehabilitation program afterwards, researchers report. ... are significant given the fact that more than 600,000 ... according to the American Heart Association (AHA). In ...
Cached Medicine News:Health News:Patients who see preferred doctor less likely to go for emergency hospital admission 2Health News:A virus similar to herpes could be a risk factor for multiple sclerosis 2Health News:Stem cell study could pave the way to treatment for age-related muscle wasting 2Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 2Health News:Halving the radiation dose in cardiac perfusion imaging is now 'feasible' 3Health News:COPD patients may breathe easier, thanks to the Wii 2Health News:COPD patients may breathe easier, thanks to the Wii 3Health News:Cardiac Rehab Can Boost Survival After Angioplasty, Study Finds 2
... system is a long term, ... clinically proven design. Available in ... correct cruciate retaining configurations. In ... of identification keeps the user ...
... Oxinium (oxidized zirconium) isn't a new implant. ... Smith & Nephew. Wear debris can be ... almost nil, addressing the needs of the ... are all improved. Initially, Oxinium is available ...
The RT-PLUS Solution is an axially supported rotation knee prosthesis for cemented implantation. The implant is available in three sizes, each of which can be combined with the next size up or down....
... Posterior Stabilized knee system was ... polyethylene wear between all articulating ... stress associated with wear in ... balanced knee with normalized quadriceps ...
Medicine Products: